Robert E. Andrews serves as Executive at Akers Biosciences Inc, where they oversee executive responsibilities. Since joining the company, Robert E. Andrews has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 30, 2015 involved receiving (via award) 48,125 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 30, 2015 | AKER | $0 | Award | 48,125 | $N/A | Discretionary |
Robert E. Andrews currently holds 48,125 shares of Akers Biosciences Inc (AKER), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert E. Andrews has been a net neutral trader of AKER stock. They have purchased $0 and sold $0 worth of shares.
Robert E. Andrews's most recent insider trade was on Dec 30, 2015, when they sold 48,125 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted